Fifth Third Bancorp
MBOT icon

Fifth Third Bancorp’s Microbot Medical MBOT Stock Holding History

Fifth Third Bancorp’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed – – 2299
2018
Q3 		$0 Buy
+1
New +$9 ﹤0.01% 2260
2018
Q2 		– Hold
0
– – – 2335
2018
Q1 		– Hold
0
– – – 2345
2014
Q4 		– Sell
-2
Closed -$5K – 2436
2014
Q3 		$5K Buy
+2
New +$5.28K ﹤0.01% 2161

Other funds holding MBOT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fifth Third Bancorp's MBOT Position: Q4 2018 in Review

Fifth Third Bancorp sold out of Microbot Medical (MBOT) in Q4 2018, closing a stake of 1 share.

Fifth Third Bancorp first reported a position in MBOT in Q3 2014 and held it in 2 quarters. The position peaked at $5K in Q3 2014. 29 funds tracked by Wall St. Rank hold MBOT as of Q4 2018.

  • Fifth Third Bancorp reported no remaining Microbot Medical position as of Q4 2018 after selling out during the quarter.
  • Fifth Third Bancorp sold 1 Microbot Medical share in Q4 2018.
  • Fifth Third Bancorp first reported a position in Microbot Medical in Q3 2014 and held it in 2 quarters.
  • Fifth Third Bancorp's Microbot Medical position peaked at $5K in Q3 2014.
  • 29 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2018.

Based on Fifth Third Bancorp's 13F filing for Q4 2018, filed 14 Feb 2019.